Secondary transitional cell carcinoma and nitrogen mustard treatment

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Transitional cell carcinoma (TCC) of the bladder in children is a rare occurrence. Cyclophosphamide is a known risk factor for the development of TCC. Other alkylating agents, such as nitrogen mustard, have not been implicated in the development of secondary adult or pediatric TCC. The role of radiotherapy in the development of secondary malignancies of the bladder remains controversial. We report a case of childhood TCC in a patient in remission from Hodgkin's lymphoma previously treated with non-cyclophosphamide chemotherapy and low-dose nodal radiotherapy.

Original languageEnglish (US)
JournalUrology
Volume65
Issue number6
DOIs
StatePublished - Jun 2005

Fingerprint

Mechlorethamine
Transitional Cell Carcinoma
Urinary Bladder
Radiotherapy
Alkylating Agents
Therapeutics
Hodgkin Disease
Cyclophosphamide
Pediatrics
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Secondary transitional cell carcinoma and nitrogen mustard treatment. / DeLair, Sean M.; deVere White, Ralph W; Kurzrock, Eric A.

In: Urology, Vol. 65, No. 6, 06.2005.

Research output: Contribution to journalArticle

@article{d2149df0a094438c9558ac4038f39cb2,
title = "Secondary transitional cell carcinoma and nitrogen mustard treatment",
abstract = "Transitional cell carcinoma (TCC) of the bladder in children is a rare occurrence. Cyclophosphamide is a known risk factor for the development of TCC. Other alkylating agents, such as nitrogen mustard, have not been implicated in the development of secondary adult or pediatric TCC. The role of radiotherapy in the development of secondary malignancies of the bladder remains controversial. We report a case of childhood TCC in a patient in remission from Hodgkin's lymphoma previously treated with non-cyclophosphamide chemotherapy and low-dose nodal radiotherapy.",
author = "DeLair, {Sean M.} and {deVere White}, {Ralph W} and Kurzrock, {Eric A}",
year = "2005",
month = "6",
doi = "10.1016/j.urology.2004.12.037",
language = "English (US)",
volume = "65",
journal = "Urology",
issn = "1527-9995",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Secondary transitional cell carcinoma and nitrogen mustard treatment

AU - DeLair, Sean M.

AU - deVere White, Ralph W

AU - Kurzrock, Eric A

PY - 2005/6

Y1 - 2005/6

N2 - Transitional cell carcinoma (TCC) of the bladder in children is a rare occurrence. Cyclophosphamide is a known risk factor for the development of TCC. Other alkylating agents, such as nitrogen mustard, have not been implicated in the development of secondary adult or pediatric TCC. The role of radiotherapy in the development of secondary malignancies of the bladder remains controversial. We report a case of childhood TCC in a patient in remission from Hodgkin's lymphoma previously treated with non-cyclophosphamide chemotherapy and low-dose nodal radiotherapy.

AB - Transitional cell carcinoma (TCC) of the bladder in children is a rare occurrence. Cyclophosphamide is a known risk factor for the development of TCC. Other alkylating agents, such as nitrogen mustard, have not been implicated in the development of secondary adult or pediatric TCC. The role of radiotherapy in the development of secondary malignancies of the bladder remains controversial. We report a case of childhood TCC in a patient in remission from Hodgkin's lymphoma previously treated with non-cyclophosphamide chemotherapy and low-dose nodal radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=20444449826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444449826&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2004.12.037

DO - 10.1016/j.urology.2004.12.037

M3 - Article

C2 - 15922437

AN - SCOPUS:20444449826

VL - 65

JO - Urology

JF - Urology

SN - 1527-9995

IS - 6

ER -